Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP
2020 · Immunity · 387 citations
https://doi.org/10.1016/j.immuni.2020.01.014
R
Robert Piskol
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
97
Papers
5.7K
Citations
25
h-index
36
i10-index
Robert Piskol is an academic researcher from Bioinformatics Institute. The author has contributed to research in topics: Biotechnology and Related Fields & Computational Drug Discovery Methods & RNA regulation and disease. The author has an h-index of 25, co-authored 83 publications.
ORCID: 0000-0001-8942-9943Papers by this author
worksCD3 bispecific antibody–induced cytokine release is dispensable for cytotoxic T cell activity
2019 · Science Translational Medicine · 174 citations
https://doi.org/10.1126/scitranslmed.aax8861
Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients
2020 · Nature Communications · 141 citations
https://doi.org/10.1038/s41467-020-19402-8
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity
2024 · Cancer Immunology Immunotherapy · 23 citations
https://doi.org/10.1007/s00262-024-03795-2
Modulation of fibronectin extracellular matrix enhances anti-tumor efficacy of immune checkpoint blockade
2025 · Cell Reports Medicine · 0 citations
https://doi.org/10.1016/j.xcrm.2025.102322
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat